Risk factors

What each company says could go wrong in its 10-K, and what changed since last year: the risks added, dropped and rewritten.

7,691 annual reports · 4,011 companies

Readings are automated and can be wrong; check the filing for the exact wording.

Older filings

Page 481 of 641 · 7,691 filings

  • U S Physical Therapy (USPH) FY2024 10-K risk factors
    35 risks

    U.S. Physical Therapy relies heavily on Medicare reimbursement and private third-party payors for revenue generation. Complex healthcare regulations, compliance audits, and corporate practice restrictions govern daily clinic operations. Recruiting and retaining qualified physical therapists and maintaining physician referral relationships drive business success.

    Filed Mar 03, 2025
  • Viridian Therapeutics (VRDN) FY2024 10-K risk factors
    65 risks

    Viridian faces ongoing net losses and an accumulated deficit of $995.9 million, relying on $717.6 million in cash to fund operations into 2027.

    Filed Mar 03, 2025
  • Vse (VSEC) FY2024 10-K risk factors
    22 risks

    VSE Corp faces heavy reliance on the aviation aftermarket and specific customer concentration like the USPS managed inventory program. The company carries significant debt totaling $430 million and is exposed to macroeconomic, supply chain, and regulatory risks.

    Filed Mar 03, 2025
  • Terawulf (WULF) FY2024 10-K risk factors
    47 risks

    TeraWulf faces primary risks from bitcoin price volatility, power constraints, high expansion capital needs, and uncertainties in its new HPC hosting strategy.

    Filed Mar 03, 2025
  • Xylem (XYL) FY2024 10-K risk factors
    28 risks

    Xylem faces major risks from international operations, supply chain disruptions, and the integration of the Evoqua acquisition. Regulatory compliance, cyber threats, and large-scale project execution risks also dominate the profile.

    Filed Mar 03, 2025
  • Rush Street Interactive (RSI) FY2024 10-K risk factors
    49 risks

    Competition, customer acquisition, regulation, and unpredictable betting outcomes dominate RSI’s online casino and sports betting risks.

    Filed Feb 28, 2025
  • Sonoco Products (SON) FY2024 10-K risk factors
    46 risks

    Eviosys and other acquisitions increase integration, execution, leverage, and international operating risks.

    Filed Feb 28, 2025
  • Gilead Sciences (GILD) FY2024 10-K risk factors
    22 risks

    HIV product revenue concentration makes maintaining market share and launching replacement therapies central business risks.

    Filed Feb 28, 2025
  • Main Street Capital (MAIN) FY2024 10-K risk factors
    61 risks

    Portfolio-company credit losses, defaults, inflation, and interest-rate pressure dominate risks to income and investment values.

    Filed Feb 28, 2025
  • Applied Optoelectronics (AAOI) FY2024 10-K risk factors
    51 risks

    Revenue is highly concentrated: Microsoft, Digicomm and Oracle together represented 91.2% of 2024 revenue.

    Filed Feb 28, 2025
  • Natera (NTRA) FY2024 10-K risk factors
    57 risks

    Revenue is concentrated in Panorama, Horizon, and Signatera, which together drive most revenue and remain central to future growth.

    Filed Feb 28, 2025
  • Ameris Bancorp (ABCB) FY2024 10-K risk factors
    36 risks

    Ameris Bancorp relies heavily on net interest income and geographic concentration in the Southeastern United States. Mortgage banking activities, credit quality in real estate loans, and regulatory compliance drive key risks. A DOJ consent order in the Jacksonville market highlights compliance exposure.

    Filed Feb 28, 2025

Companies covered

4,011 companies

371 more under A